IVERIC bio, Inc. (ISEE) Social Stream



IVERIC bio, Inc. (ISEE): $9.93

0.53 (+5.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ISEE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

IVERIC bio Inc (ISEE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ISEE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-13 4 $25 $20 $22 $16.32 34.8%
2021-11-10 4 $26 $21 $23.5 $16.32 44%
2022-01-13 4 $26 $22 $23.75 $16.32 45.53%
2022-02-25 5 $26 $22 $24 $16.32 47.06%
2022-03-03 7 $27 $22 $24.5 $16.32 50.12%
2022-03-22 7 $27 $22 $24.857 $16.32 52.31%

The Trend in the Analyst Price Target


ISEE's average price target has moved up $10.86 over the prior 26 months.

ISEE reports an average of 68.83% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-14 4 25 20 22.000 15.36 43.23%
2021-11-10 4 26 21 23.500 17.03 37.99%
2021-11-10 4 26 22 23.750 17.03 39.46%
2022-03-03 7 27 22 24.500 15.50 58.06%
2022-03-22 7 27 22 24.857 16.83 47.69%

ISEE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.07 6 1 0 0 0 7

The Trend in the Broker Recommendations


Over the past 59 days, ISEE's average broker recommendation rating worsened by 0.14.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how IVERIC bio Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -75.75% of that group.
  • In terms of how IVERIC bio Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 158.57% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, IVERIC bio Inc's average analyst price target is higher than 209.3% of them.
  • ISEE has a higher number of analysts covering the stock than 236.18% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IVERIC bio Inc are IRWD, INVA, and INSM.

What is the outlook for ISEE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5751 seconds.